Conduent Technology and Expertise Plays Critical Role in Public Health Response to Monkeypox
Conduent (Nasdaq: CNDT) has announced the expansion of its Maven® Disease Surveillance & Outbreak Management Platform, which has been crucial for managing infectious diseases like COVID-19 and monkeypox across 28 jurisdictions globally. The platform integrates recommendations from the CDC, aiding public health organizations amid a public health emergency. With a history of two decades in disease surveillance, Maven supports extensive data sharing and contact tracing to combat outbreaks, while employing seasoned epidemiologists for enhanced public health response.
- Maven platform supports public health initiatives during emergencies, including monkeypox.
- Engagement in global disease surveillance for 20 years, enhancing credibility.
- Integration with CDC recommendations improves response capabilities.
- Public health organizations remain stretched thin, indicating resource challenges.
- Ongoing spread of infectious diseases may result in increased operational pressure.
Company’s Maven® Disease Surveillance & Outbreak Management Platform and epidemiologist team deliver comprehensive support to agencies across 28 jurisdictions, worldwide
The technology platform has been integral in the management of such diseases as COVID-19, Ebola, Zika, measles, tuberculosis, HIV, STDs, influenza, polio and monkeypox
FLORHAM PARK, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions company, has been deeply engaged in disease surveillance for the past 20 years with the development of the Maven® Disease Surveillance & Outbreak Management Platform. Maven has enabled health professionals to quickly scale their response to the public health emergency declared for monkeypox by incorporating the recommendations and requirements of the Centers for Disease Control and Prevention (CDC) into the platform.
In addition to regular updates to Maven’s contact tracing, case, outbreak, and incident management capabilities, Conduent employs seasoned epidemiologists to support public health organizations (PHO) that have been overextended by the sustained response to COVID-19.
Maven is used by public health officials, medical providers, and epidemiologists to facilitate the core mission of public health — prevention, mitigation, and protection — during an outbreak crisis. The U.S. deemed monkeypox a public health emergency in early August, giving PHOs access to additional resources to ramp up education, testing, and contact tracing in their jurisdictions and to improve coordination with local health and community-based organizations. The declaration also requires more robust and immediate data sharing with the CDC, which Maven enables.
“While public health teams remain stretched thin for resources and time as the spread of infectious disease continues, the need to respond rapidly to new and ongoing threats to their communities’ health remains vital. The Maven technology platform, combined with the knowledge of Conduent’s experienced epidemiologists, supports our clients in sustaining heightened vigilance to stop the spread of highly contagious diseases such as monkeypox,” said Lydie Quebe, General Manager of Government Health Solutions at Conduent. “Maven is highly configurable to meet the needs of specific geographies and populations and automates inter-agency information sharing to achieve faster containment of infectious diseases.”
Monkeypox marks the seventh global health emergency declared by the World Health Organization (WHO) over the last 15 years. In each instance, Maven has helped PHO worldwide accomplish the work of protecting public health while securely tracing and monitoring patients infected with, or exposed to, dire communicable diseases. Maven is used across 28 jurisdictions —in the U.S. and internationally— to manage cases of more than 100 reportable conditions. The technology platform has been, and remains, integral in the management of such diseases as COVID-19, Ebola, Zika, measles, tuberculosis, HIV, STDs, influenza, polio and monkeypox.
About Conduent
Conduent delivers mission-critical services and solutions on behalf of businesses and governments – creating exceptional outcomes for its clients and the millions of people who count on them. Through our dedicated people, processes, and technologies, Conduent solutions and services enhance customer experience, increase efficiencies, reduce costs, and improve performance for most Fortune 100 companies and more than 500 government entities. Whether it’s touching three out of every four health insured lives and delivering
Media Contact:
Sharon Lakes, Conduent, +1-469-750-5403, sharon.lakes2@conduent.com
Investor Relations Contact:
Giles Goodburn, Conduent, +1-203-216-3546, ir@conduent.com
Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives, and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.
Trademarks
Conduent is a trademark of Conduent Incorporated in the United States and/or other countries. Other names may be trademarks of their respective owners.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/50a8b2bc-5b92-46c6-9c8b-637b8d45735f
FAQ
What is the Maven platform used for by Conduent?
How many jurisdictions utilize the Maven platform?
What diseases has the Maven platform helped manage?
What role do epidemiologists play in Conduent's Maven platform?
How does the Maven platform support CDC recommendations?
